The syndrome of rhabdomyolysis: Complications and treatment

Yiannis S. Chatzizisis, Gesthimani Misirli, Apostolos I. Hatzitolios, George D. Giannoglou

Research output: Contribution to journalReview article

128 Citations (Scopus)

Abstract

Rhabdomyolysis is a syndrome of skeletal muscle cell damage that leads to the release of toxic intracellular material into the systemic circulation. The pathogenesis of rhabdomyolysis is based on an increase in free ionized calcium in the cytoplasm. Its main complications include (a) acute renal failure, which is triggered by renal vasoconstriction and ischemia, (b) myoglobin cast formation in the distal convoluted tubules, and (c) direct renal toxic effect of myoglobin on the epithelial cells of proximal convoluted tubules. Other major complications include electrolyte disorders, such as hyperkalemia, which may cause cardiac arrhythmias, metabolic acidosis, hyperphosphatemia, early hypocalcemia, and late hypercalcemia. Compartmental syndrome and disseminated intravascular coagulopathy may also emerge. The management of myoglobinuric acute renal failure includes aggressive fluid administration to restore the hypovolemia and urine alkalization. The concomitant electrolyte and metabolic disorders should also be treated appropriately; hemodialysis should be considered when life-threatening hyperkalemia and metabolic acidosis exist. In the case of compartmental syndrome, it is important to monitor the intra-compartmental pressure and to perform fasciotomy, if required. When diagnosed early and if the appropriate treatment is initiated promptly, the complications of rhabdomyolysis are preventable and the syndrome has a good prognosis.

Original languageEnglish (US)
Pages (from-to)568-574
Number of pages7
JournalEuropean Journal of Internal Medicine
Volume19
Issue number8
DOIs
StatePublished - Dec 1 2008

Fingerprint

Rhabdomyolysis
Hyperkalemia
Myoglobin
Poisons
Acidosis
Acute Kidney Injury
Electrolytes
Hyperphosphatemia
Kidney
Hypovolemia
Hypocalcemia
Hypercalcemia
Therapeutics
Vasoconstriction
Muscle Cells
Renal Dialysis
Cardiac Arrhythmias
Cytoplasm
Skeletal Muscle
Ischemia

Keywords

  • Acute renal failure
  • Compartmental syndrome
  • Electrolyte disturbances
  • Metabolic acidosis
  • Rhabdomyolysis

ASJC Scopus subject areas

  • Internal Medicine

Cite this

The syndrome of rhabdomyolysis : Complications and treatment. / Chatzizisis, Yiannis S.; Misirli, Gesthimani; Hatzitolios, Apostolos I.; Giannoglou, George D.

In: European Journal of Internal Medicine, Vol. 19, No. 8, 01.12.2008, p. 568-574.

Research output: Contribution to journalReview article

Chatzizisis, Yiannis S. ; Misirli, Gesthimani ; Hatzitolios, Apostolos I. ; Giannoglou, George D. / The syndrome of rhabdomyolysis : Complications and treatment. In: European Journal of Internal Medicine. 2008 ; Vol. 19, No. 8. pp. 568-574.
@article{4648f70efc9645098e018c3a59f1b7be,
title = "The syndrome of rhabdomyolysis: Complications and treatment",
abstract = "Rhabdomyolysis is a syndrome of skeletal muscle cell damage that leads to the release of toxic intracellular material into the systemic circulation. The pathogenesis of rhabdomyolysis is based on an increase in free ionized calcium in the cytoplasm. Its main complications include (a) acute renal failure, which is triggered by renal vasoconstriction and ischemia, (b) myoglobin cast formation in the distal convoluted tubules, and (c) direct renal toxic effect of myoglobin on the epithelial cells of proximal convoluted tubules. Other major complications include electrolyte disorders, such as hyperkalemia, which may cause cardiac arrhythmias, metabolic acidosis, hyperphosphatemia, early hypocalcemia, and late hypercalcemia. Compartmental syndrome and disseminated intravascular coagulopathy may also emerge. The management of myoglobinuric acute renal failure includes aggressive fluid administration to restore the hypovolemia and urine alkalization. The concomitant electrolyte and metabolic disorders should also be treated appropriately; hemodialysis should be considered when life-threatening hyperkalemia and metabolic acidosis exist. In the case of compartmental syndrome, it is important to monitor the intra-compartmental pressure and to perform fasciotomy, if required. When diagnosed early and if the appropriate treatment is initiated promptly, the complications of rhabdomyolysis are preventable and the syndrome has a good prognosis.",
keywords = "Acute renal failure, Compartmental syndrome, Electrolyte disturbances, Metabolic acidosis, Rhabdomyolysis",
author = "Chatzizisis, {Yiannis S.} and Gesthimani Misirli and Hatzitolios, {Apostolos I.} and Giannoglou, {George D.}",
year = "2008",
month = "12",
day = "1",
doi = "10.1016/j.ejim.2007.06.037",
language = "English (US)",
volume = "19",
pages = "568--574",
journal = "European Journal of Internal Medicine",
issn = "0953-6205",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - The syndrome of rhabdomyolysis

T2 - Complications and treatment

AU - Chatzizisis, Yiannis S.

AU - Misirli, Gesthimani

AU - Hatzitolios, Apostolos I.

AU - Giannoglou, George D.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Rhabdomyolysis is a syndrome of skeletal muscle cell damage that leads to the release of toxic intracellular material into the systemic circulation. The pathogenesis of rhabdomyolysis is based on an increase in free ionized calcium in the cytoplasm. Its main complications include (a) acute renal failure, which is triggered by renal vasoconstriction and ischemia, (b) myoglobin cast formation in the distal convoluted tubules, and (c) direct renal toxic effect of myoglobin on the epithelial cells of proximal convoluted tubules. Other major complications include electrolyte disorders, such as hyperkalemia, which may cause cardiac arrhythmias, metabolic acidosis, hyperphosphatemia, early hypocalcemia, and late hypercalcemia. Compartmental syndrome and disseminated intravascular coagulopathy may also emerge. The management of myoglobinuric acute renal failure includes aggressive fluid administration to restore the hypovolemia and urine alkalization. The concomitant electrolyte and metabolic disorders should also be treated appropriately; hemodialysis should be considered when life-threatening hyperkalemia and metabolic acidosis exist. In the case of compartmental syndrome, it is important to monitor the intra-compartmental pressure and to perform fasciotomy, if required. When diagnosed early and if the appropriate treatment is initiated promptly, the complications of rhabdomyolysis are preventable and the syndrome has a good prognosis.

AB - Rhabdomyolysis is a syndrome of skeletal muscle cell damage that leads to the release of toxic intracellular material into the systemic circulation. The pathogenesis of rhabdomyolysis is based on an increase in free ionized calcium in the cytoplasm. Its main complications include (a) acute renal failure, which is triggered by renal vasoconstriction and ischemia, (b) myoglobin cast formation in the distal convoluted tubules, and (c) direct renal toxic effect of myoglobin on the epithelial cells of proximal convoluted tubules. Other major complications include electrolyte disorders, such as hyperkalemia, which may cause cardiac arrhythmias, metabolic acidosis, hyperphosphatemia, early hypocalcemia, and late hypercalcemia. Compartmental syndrome and disseminated intravascular coagulopathy may also emerge. The management of myoglobinuric acute renal failure includes aggressive fluid administration to restore the hypovolemia and urine alkalization. The concomitant electrolyte and metabolic disorders should also be treated appropriately; hemodialysis should be considered when life-threatening hyperkalemia and metabolic acidosis exist. In the case of compartmental syndrome, it is important to monitor the intra-compartmental pressure and to perform fasciotomy, if required. When diagnosed early and if the appropriate treatment is initiated promptly, the complications of rhabdomyolysis are preventable and the syndrome has a good prognosis.

KW - Acute renal failure

KW - Compartmental syndrome

KW - Electrolyte disturbances

KW - Metabolic acidosis

KW - Rhabdomyolysis

UR - http://www.scopus.com/inward/record.url?scp=56949095515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56949095515&partnerID=8YFLogxK

U2 - 10.1016/j.ejim.2007.06.037

DO - 10.1016/j.ejim.2007.06.037

M3 - Review article

C2 - 19046720

AN - SCOPUS:56949095515

VL - 19

SP - 568

EP - 574

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

SN - 0953-6205

IS - 8

ER -